{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:59:06Z","timestamp":1774396746504,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"DOI":"10.7759\/cureus.94828","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T04:24:54Z","timestamp":1760761494000},"source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Outcomes of Simultaneous Integrated Boost in Node-Positive Cervical Cancer: A Single-Institution Retrospective Study"],"prefix":"10.7759","author":[{"given":"Sreenivasa Rao","family":"Bonala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bala Venkat","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cherwin","family":"Venati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorakayapet Arumugam","family":"Raja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"erlay J, Ervik M, Lam F, et al.. India Fact Sheet (GLOBOCAN 2022). Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2024. (2024). Accessed: January 31, 2024: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/356-india-fact-sheet.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002225.pub2","article-title":"Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix","volume":"2005","author":"Green J","year":"2005","unstructured":"Green J, Kirwan J, Tierney J, et al.. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev. 2005, 2005:CD002225. 10.1002\/14651858.CD002225.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2018.11.002","article-title":"Management of nodal disease in advanced cervical cancer","volume":"29","author":"J\u00fcrgenliemk-Schulz IM","year":"2019","unstructured":"J\u00fcrgenliemk-Schulz IM, Beriwal S, de Leeuw AA, et al.. Management of nodal disease in advanced cervical cancer. Semin Radiat Oncol. 2019, 29:158-65. 10.1016\/j.semradonc.2018.11.002","journal-title":"Semin Radiat Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla N","year":"2019","unstructured":"Bhatla N, Berek JS, Cuello Fredes M, et al.. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019, 145:129-35. 10.1002\/ijgo.12749","journal-title":"Int J Gynaecol Obstet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma","volume":"340","author":"Keys HM","year":"1999","unstructured":"Keys HM, Bundy BN, Stehman FB, et al.. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999, 340:1154-61. 10.1056\/NEJM199904153401503","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.4.966","article-title":"Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix","volume":"20","author":"Pearcey R","year":"2002","unstructured":"Pearcey R, Brundage M, Drouin P, et al.. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol. 2002, 20:966-72. 10.1200\/JCO.2002.20.4.966","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose PG","year":"1999","unstructured":"Rose PG, Bundy BN, Watkins EB, et al.. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999, 340:1144-53. 10.1056\/NEJM199904153401502","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1997.4865","article-title":"Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma","volume":"67","author":"Malfetano JH","year":"1997","unstructured":"Malfetano JH, Keys H, Cunningham MJ, Gibbons S, Ambros R. Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma. Gynecol Oncol. 1997, 67:203-7. 10.1006\/gyno.1997.4865","journal-title":"Gynecol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(98)00267-3","article-title":"Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A Gynecologic Oncology Group study","volume":"1","author":"Varia MA","year":"1998","unstructured":"Varia MA, Bundy BN, Deppe G, et al.. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys. 1998, 1:1015-23. 10.1016\/s0360-3016(98)00267-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting CM","year":"2011","unstructured":"Nutting CM, Morden JP, Harrington KJ, et al.. PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011, 12:127-36. 10.1016\/S1470-2045(10)70290-4","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12736","article-title":"Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma","volume":"8","author":"Chen JL","year":"2017","unstructured":"Chen JL, Huang YS, Kuo SH, Hong RL, Ko JY, Lou PJ, Wang CW. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma. Oncotarget. 2017, 8:14068-77. 10.18632\/oncotarget.12736","journal-title":"Oncotarget"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(01)01664-9","article-title":"Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation","volume":"51","author":"Portelance L","year":"2001","unstructured":"Portelance L, Chao KS, Grigsby PW, Bennet H, Low D. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 2001, 51:261-6. 10.1016\/s0360-3016(01)01664-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010517","article-title":"Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy","volume":"97","author":"Choi KH","year":"2018","unstructured":"Choi KH, Kim JY, Lee DS, et al.. Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy. Medicine. 2018, 97:e0517. 10.1097\/MD.0000000000010517","journal-title":"Medicine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrt097. Epub 2013 Aug 2","article-title":"Impact of boost irradiation on pelvic lymph node control in patients with cervical cancer","volume":"55","author":"Wakatsuki M","year":"2013","unstructured":"Wakatsuki M, Ohno T, Kato S, et al.. Impact of boost irradiation on pelvic lymph node control in patients with cervical cancer. J Radiat Res. 2013, 55:139-45. 10.1093\/jrr\/rrt097. Epub 2013 Aug 2","journal-title":"J Radiat Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.12.023","article-title":"Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer","volume":"68","author":"Beriwal S","year":"20071","unstructured":"Beriwal S, Gan GN, Heron DE, et al.. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 20071, 68:166-71. 10.1016\/j.ijrobp.2006.12.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.08.013","article-title":"Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: Analysis of regional control and recurrence patterns in the positron emission tomography\/computed tomography era","volume":"1","author":"Vargo JA","year":"2014","unstructured":"Vargo JA, Kim H, Choi S, et al.. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: Analysis of regional control and recurrence patterns in the positron emission tomography\/computed tomography era. Int J Radiat Oncol Biol Phys. 2014, 1:1091-8. 10.1016\/j.ijrobp.2014.08.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184647","article-title":"Simultaneous integrated boost for dose escalation in node-positive cervical cancer: 5-year experience in a single institution","volume":"15","author":"Cheung ES","year":"2023","unstructured":"Cheung ES, Law FC, Fung NT, et al.. Simultaneous integrated boost for dose escalation in node-positive cervical cancer: 5-year experience in a single institution. Cancers. 2023, 15:4647. 10.3390\/cancers15184647","journal-title":"Cancers"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7150\/jca.29301","article-title":"Efficacy and toxicity of IMRT-based simultaneous integrated boost for the definitive management of positive lymph nodes in patients with cervical cancer","volume":"10","author":"Dang YZ","year":"2019","unstructured":"Dang YZ, Li P, Li JP, et al.. Efficacy and toxicity of IMRT-based simultaneous integrated boost for the definitive management of positive lymph nodes in patients with cervical cancer. J Cancer. 2019, 10:1103-9. 10.7150\/jca.29301","journal-title":"J Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-021-01818-1","article-title":"High dose simultaneous integrated boost for node positive cervical cancer","volume":"16","author":"Jayatilakebanda I","year":"2021","unstructured":"Jayatilakebanda I, Tsang YM, Hoskin P. High dose simultaneous integrated boost for node positive cervical cancer. Radiat Oncol. 2021, 16:92. 10.1186\/s13014-021-01818-1","journal-title":"Radiat Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tipsro.2021.02.009","article-title":"Prospective observational study evaluating acute and delayed treatment related toxicities of prophylactic extended field volumetric modulated arc therapy with concurrent cisplatin in cervical cancer patients with pelvic lymph node metastasis","volume":"17","author":"Ballari N","year":"2021","unstructured":"Ballari N, Rai B, Bahl A, Mittal BR, Ghoshal S. Prospective observational study evaluating acute and delayed treatment related toxicities of prophylactic extended field volumetric modulated arc therapy with concurrent cisplatin in cervical cancer patients with pelvic lymph node metastasis. Tech Innov Patient Support Radiat Oncol. 2021, 17:48-56. 10.1016\/j.tipsro.2021.02.009","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.07.023","article-title":"Impact of nodal boost irradiation and MR-based brachytherapy on oncologic outcomes in node positive cervical cancer","volume":"163","author":"Tiwari R","year":"2021","unstructured":"Tiwari R, Narayanan GS, Reddy VP, et al.. Impact of nodal boost irradiation and MR-based brachytherapy on oncologic outcomes in node positive cervical cancer. Gynecol Oncol. 2021, 163:110-6. 10.1016\/j.ygyno.2021.07.023","journal-title":"Gynecol Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.25259\/asjo-2022-26-(370)","article-title":"An Indian data on response of positive pelvic lymph nodes in carcinoma cervix patients treated with simultaneous integrated boost using volumetric modulated arc radiation therapy","volume":"9","author":"Perumareddy V","year":"2023","unstructured":"Perumareddy V, Shivananjappa R, Geeta SN, Tiwari R. An Indian data on response of positive pelvic lymph nodes in carcinoma cervix patients treated with simultaneous integrated boost using volumetric modulated arc radiation therapy. Asian J Oncol. 2023, 9:9. 10.25259\/asjo-2022-26-(370)","journal-title":"Asian J Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2022.11.010","article-title":"Management of radiographically positive pelvic and\/or para-aortic lymph nodes during primary chemoradiation therapy for cervix cancer","volume":"13","author":"Brower JV","year":"2023","unstructured":"Brower JV, Bradley KA, Russo AL. Management of radiographically positive pelvic and\/or para-aortic lymph nodes during primary chemoradiation therapy for cervix cancer. Pract Radiat Oncol. 2023, 13:246-50. 10.1016\/j.prro.2022.11.010","journal-title":"Pract Radiat Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2018.01.001","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter R","year":"2018","unstructured":"P\u00f6tter R, Tanderup K, Kirisits C, et al.. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018, 9:48-60. 10.1016\/j.ctro.2018.01.001","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.03.038","article-title":"Change in patterns of failure after image-guided brachytherapy for cervical cancer: Analysis from the retro EMBRACE Study","volume":"15","author":"Tan LT","year":"2019","unstructured":"Tan LT, P\u00f6tter R, Sturdza A, et al.. Change in patterns of failure after image-guided brachytherapy for cervical cancer: Analysis from the retro EMBRACE Study. Int J Radiat Oncol Biol Phys. 2019, 15:895-902. 10.1016\/j.ijrobp.2019.03.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.10.075","article-title":"Gyn IMRT Consortium. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervical cancer","volume":"79","author":"Lim K","year":"2011","unstructured":"Lim K, Small W Jr, Portelance L, et al.. Gyn IMRT Consortium. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2011, 79:348-55. 10.1016\/j.ijrobp.2009.10.075","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.05.062","article-title":"Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapy","volume":"63","author":"Taylor A","year":"2005","unstructured":"Taylor A, Rockall AG, Reznek RH, et al.. Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2005, 63:1604-12. 10.1016\/j.ijrobp.2005.05.062","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas","volume":"83","author":"Gay HA","year":"2012","unstructured":"Gay HA, Barthold HJ, O'Meara E, et al.. Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys. 2012, 83:353-62. 10.1016\/j.ijrobp.2012.01.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer EA","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al.. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45:228-47. 10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox JD","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995, 31:1341-6. 10.1016\/0360-3016(95)00060-C","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/423950-long-term-outcomes-of-simultaneous-integrated-boost-in-node-positive-cervical-cancer-a-single-institution-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T04:24:57Z","timestamp":1760761497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/423950-long-term-outcomes-of-simultaneous-integrated-boost-in-node-positive-cervical-cancer-a-single-institution-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.94828","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,17]]}}}